Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Diphenhydramine hydrochloride
Cat. No.:
OB0225LY-0102
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Diphenhydramine hydrochloride is a common antihistamine, often used for allergy symptoms, insomnia, and as an ingredient in refrigerated medications.
Synonym:
Diphenhydramine HCl; DPH; 147-24-0; 2-(Benzhydryloxy)-N, N-dimethylethanamine; Ethanamine, 2-(diphenylmethoxy)-N, N-dimethyl-; O-Benzhydryldimethylaminoethanol; 2-(Benzhydryloxy)-N, N-dimethylethylamine
CAS No.:
147-24-0
Compound CID:
3100
Formula:
C17H22ClNO
Formula Weight:
291.82
Specification
Relative Density:
0.997 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Diphenhydramine hydrochloride can be used for drug development in the areas of pruritus and skin diseases, allergic reactions, Parkinson's disease, hypnosis.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
GPCR/G protein; Immunology/Inflammation; Neuronal signaling
Plate Number:
AOCL-2
Plate Location:
c5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 154.2 mM
